News
Grapheal Raises EUR1.9 Million to Advance Development of Embedded Biosensing Technology and Application in Digital COVID Testing and Wound Monitoring [09-02-2021]
Grapheal, a developer of graphene-based embedded biosensors for on-site diagnostics and remote patient monitoring, announced today that it has raised a total of EUR1.9 million in equity and non-dilutive sources, including seed financing from Novalis Biotech’s Acceleration Fund, several innovation grants, and Bpifrance convertible notes and loans.
Related News
Researchers create tunable superconductivity in magic-angle twisted trilayer graphene [02-03-2021]
Graphene
Terahertz imaging of graphene could promote industrialization [02-03-2021]
Graphene
New technique may enable large-area integration of 2D materials [02-03-2021]
Graphene
Taking graphene out of the laboratory and into the real world [22-02-2021]
Graphene
Tiny graphene microchips could make your phones and laptops thousands of times faster, say scientists [15-02-2021]
Nanoelectronics, Graphene
CLOSE
Sitemap
  NEWS
  CONFERENCES
  JOBS
  PH REPORTS

© Phantoms Foundation 2020